Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Current Molecular Biology Reports

• Publication date

  2019-02-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s40610-019-0118-1PMID 31871877PMCID PMC6927676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults With X‐Linked Hypophosphatemia: Week 24 Primary Analysis

  2018cited by this paper
• The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.

  2018cited by this paper
• Burosumab Therapy in Children with X‐Linked Hypophosphatemia

  2018cited by this paper
• Randomized trial of intravenous iron-induced hypophosphatemia.

  2018cited by this paper
• Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters

  2018cited by this paper
• CYP3A4 mutation causes vitamin D–dependent rickets type 3

  2018cited by this paper
• Phosphate as a Signaling Molecule and Its Sensing Mechanism.

  2018cited by this paper
• Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis.

  2018cited by this paper
• Hypophosphatemia as a sign of malnutrition in older hospitalized patients

  2018cited by this paper
• Rare, genetically conditioned forms of rickets: Differential diagnosis and advances in diagnostics and treatment

  2018cited by this paper
• Vitamin D–Dependent Rickets Type 1B (25‐Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?

  2017cited by this paper
• Genetic Causes of Rickets

  2017cited by this paper
• Kidney Tubular Ablation of Ocrl/Inpp5b Phenocopies Lowe Syndrome Tubulopathy.

  2017cited by this paper
• Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients

  2016cited by this paper
• A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia

  2016cited by this paper
• Multiple faces of fibroblast growth factor-23

  2016cited by this paper
• Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms.

  2016cited by this paper
• Membrane and Integrative Nuclear Fibroblastic Growth Factor Receptor (FGFR) Regulation of FGF-23*

  2015cited by this paper
• Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1

  2015cited by this paper
• Dietary phosphorus intake and health1-3.

  2014cited by this paper
• Management of adult diabetic ketoacidosis

  2014cited by this paper
• Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23

  2014cited by this paper
• Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis

  2014cited by this paper
• An integrated understanding of the physiological response to elevated extracellular phosphate

  2013cited by this paper
• Change of serum phosphate level and clinical outcome of hypophosphatemia in massive burn patient

  2012cited by this paper
• Refeeding hypophosphataemia is more common in enteral than parenteral feeding in adult in patients.

  2011cited by this paper
• A clinician's guide to X‐linked hypophosphatemia

  2011cited by this paper
• The bone and beyond: 'Dem bones' are made for more than walking

  2011cited by this paper
• A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD).

  2011cited by this paper
• Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling

  2011cited by this paper
• Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations.

  2010cited by this paper
• Relevant use of Klotho in FGF19 subfamily signaling system in vivo

  2010cited by this paper
• Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets.

  2010cited by this paper
• Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.

  2010cited by this paper
• Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene.

  2010cited by this paper
• Intestinal npt2b plays a major role in phosphate absorption and homeostasis.

  2009cited by this paper
• Survey of the Enthesopathy of X-Linked Hypophosphatemia and Its Characterization in Hyp Mice

  2009cited by this paper
• Novel regulators of Fgf23 expression and mineralization in Hyp bone.

  2009cited by this paper
• Novel mechanisms in the regulation of phosphorus homeostasis.

  2009cited by this paper
• Endocrine functions of bone in mineral metabolism regulation.

  2008cited by this paper
• Pathogenic role of Fgf23 in Dmp1-null mice.

  2008cited by this paper
• Anti‐FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23

  2008cited by this paper
• Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.

  2008cited by this paper
• Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.

  2008cited by this paper
• A translocation causing increased α-Klotho level results in hypophosphatemic rickets and hyperparathyroidism

  2008cited by this paper
• betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.

  2008cited by this paper
• Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.

  2007cited by this paper
• Pathogenic role of Fgf23 in Hyp mice.

  2006cited by this paper
• Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis.

  2006cited by this paper
• Klotho converts canonical FGF receptor into a specific receptor for FGF23

  2006cited by this paper
• Proximal tubular handling of phosphate: A molecular perspective.

  2006cited by this paper
• Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals.

  2006cited by this paper
• Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism

  2006cited by this paper
• Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis

  2006cited by this paper
• Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed.

  2005cited by this paper
• Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23.

  2005cited by this paper
• Overexpression of Human PHEX Under the Human β‐Actin Promoter Does Not Fully Rescue the Hyp Mouse Phenotype

  2005cited by this paper
• Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.

  2005cited by this paper
• An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

  2005cited by this paper
• The role of NHERF‐1 in the regulation of renal proximal tubule sodium–hydrogen exchanger 3 and sodium‐dependent phosphate cotransporter 2a

  2005cited by this paper
• Hypophosphatemia: an update on its etiology and treatment.

  2005cited by this paper
• Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

  2004cited by this paper
• Expression of SIBLINGs and Their Partner MMPs in Salivary Glands

  2004cited by this paper
• Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice.

  2004cited by this paper
• Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.

  2004cited by this paper
• Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

  2004cited by this paper
• Regulation of gene expression by dietary Ca2+ in kidneys of 25-hydroxyvitamin D3-1 alpha-hydroxylase knockout mice.

  2004cited by this paper
• FGF23 is processed by proprotein convertases but not by PHEX.

  2004cited by this paper
• Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.

  2004cited by this paper
• Evidence for a bone-kidney axis regulating phosphate homeostasis.

  2003cited by this paper
• Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX*

  2003cited by this paper
• Overexpression of Phex in Osteoblasts Fails to Rescue the Hyp Mouse Phenotype*

  2002cited by this paper
• Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression.

  2002cited by this paper
• Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin

  2002cited by this paper
• Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

  2001cited by this paper
• Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: a perPHEXing problem.

  2001cited by this paper
• FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.

  2001cited by this paper
• Analysis of recombinant Phex: an endopeptidase in search of a substrate.

  2001cited by this paper
• Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.

  2001cited by this paper
• Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.

  2000cited by this paper
• Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

  1998cited by this paper
• Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome

  1997cited by this paper
• Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

  1997cited by this paper
• Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme.

  1996cited by this paper
• Severe hypophosphatemia in hospitalized patients.

  1988cited by this paper
• Phosphate therapy in diabetic ketoacidosis.

  1982cited by this paper

• Indications for the evaluation and supplementation of hypophosphatemia: an umbrella systematic review of reviews and guidelines

  2025influential citation
• Calcium, Phosphate, and Vitamin D Status in Patients with Sarcoidosis—Associations with Disease Activity and Symptoms

  2023cites this paper
• Uncovering genetic causes of hypophosphatemia

  2023cites this paper
• Hypo- and Hyperphosphatemia at Admission as Independent Factors of Mortality of COVID-19 Patients: Findings from a Retrospective Cohort Study

  2022cites this paper
• Phosphorus levels in children treated with intravenous ferric carboxymaltose

  2021cites this paper
• FGF23 functions and disease.

  2021cites this paper
• Familial Hyperparathyroidism

  2021cites this paper
• Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy

  2021cites this paper
• Parenteral iron therapy and phosphorus homeostasis: A review

  2021influential citation
• The emerging role of phosphorus in human health.

  2021cites this paper
• Biological stenciling of mineralization in the skeleton: Local enzymatic removal of inhibitors in the extracellular matrix.

  2020cites this paper
• Metabonomic analysis of hypophosphatemic laying fatigue syndrome in laying hens.

  2020cites this paper
• Saudi Journal of Medicine and Public Health

  year unknowncites this paper